These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28921443)

  • 41. Development of mucoadhesive drug delivery system using phenylboronic acid functionalized poly(D,L-lactide)-b-dextran nanoparticles.
    Liu S; Jones L; Gu FX
    Macromol Biosci; 2012 Dec; 12(12):1622-6. PubMed ID: 23165800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.
    Mattu C; Pabari RM; Boffito M; Sartori S; Ciardelli G; Ramtoola Z
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):463-72. PubMed ID: 23916461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery.
    Williford JM; Santos JL; Shyam R; Mao HQ
    Biomater Sci; 2015 Jul; 3(7):894-907. PubMed ID: 26146550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior.
    Karavelidis V; Karavas E; Giliopoulos D; Papadimitriou S; Bikiaris D
    Int J Nanomedicine; 2011; 6():3021-32. PubMed ID: 22162659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester.
    Jäger E; Jäger A; Chytil P; Etrych T; Ríhová B; Giacomelli FC; Stěpánek P; Ulbrich K
    J Control Release; 2013 Jan; 165(2):153-61. PubMed ID: 23178950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New thermosensitive nanoparticles prepared by biocompatible pegylated aliphatic polyester block copolymers for local cancer treatment.
    Karavelidis V; Bikiaris D; Avgoustakis K
    J Pharm Pharmacol; 2015 Feb; 67(2):215-30. PubMed ID: 25616209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fabrication of composite poly(d,l-lactide)/montmorillonite nanoparticles for controlled delivery of acetaminophen by solvent-displacement method using glass capillary microfluidics.
    Othman R; Vladisavljević GT; Thomas NL; Nagy ZK
    Colloids Surf B Biointerfaces; 2016 May; 141():187-195. PubMed ID: 26852102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biodegradable sirolimus-loaded poly(lactide) nanoparticles as drug delivery system for the prevention of in-stent restenosis in coronary stent application.
    Luderer F; Löbler M; Rohm HW; Gocke C; Kunna K; Köck K; Kroemer HK; Weitschies W; Schmitz KP; Sternberg K
    J Biomater Appl; 2011 May; 25(8):851-75. PubMed ID: 20237179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium.
    Balzus B; Sahle FF; Hönzke S; Gerecke C; Schumacher F; Hedtrich S; Kleuser B; Bodmeier R
    Eur J Pharm Biopharm; 2017 Jun; 115():122-130. PubMed ID: 28189623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic Monoclonal Antibodies Delivery for the Glioblastoma Treatment.
    Sousa F; Moura RP; Moreira E; Martins C; Sarmento B
    Adv Protein Chem Struct Biol; 2018; 112():61-80. PubMed ID: 29680243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poly(amino acid)-polyester graft copolymer nanoparticles for the acid-mediated release of doxorubicin.
    Price DJ; Khuphe M; Davies RPW; McLaughlan JR; Ingram N; Thornton PD
    Chem Commun (Camb); 2017 Aug; 53(62):8687-8690. PubMed ID: 28722060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic biodegradable polyesters for implantable controlled-release devices.
    Pothupitiya JU; Zheng C; Saltzman WM
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1351-1364. PubMed ID: 36197839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thermosensitive nanoparticles self-assembled from PCL-b-PEO-b-PNIPAAm triblock copolymers and their potential for controlled drug release.
    Sun P; Zhang Y; Shi L; Gan Z
    Macromol Biosci; 2010 Jun; 10(6):621-31. PubMed ID: 20166233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
    Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
    Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanoparticles for paclitaxel delivery: a comparative study of different types of dendritic polyesters and their degradation behavior.
    Reul R; Renette T; Bege N; Kissel T
    Int J Pharm; 2011 Apr; 407(1-2):190-6. PubMed ID: 21256945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres.
    Marquette S; Peerboom C; Yates A; Denis L; Langer I; Amighi K; Goole J
    Int J Pharm; 2014 Aug; 470(1-2):41-50. PubMed ID: 24792974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell surface receptor targeted biomimetic apatite nanocrystals for cancer therapy.
    Iafisco M; Delgado-Lopez JM; Varoni EM; Tampieri A; Rimondini L; Gomez-Morales J; Prat M
    Small; 2013 Nov; 9(22):3834-44. PubMed ID: 23606568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles.
    Owen SC; Patel N; Logie J; Pan G; Persson H; Moffat J; Sidhu SS; Shoichet MS
    J Control Release; 2013 Dec; 172(2):395-404. PubMed ID: 23880472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics, biocompatibility and bioavailability of a controlled release monoclonal antibody formulation.
    Schweizer D; Vostiar I; Heier A; Serno T; Schoenhammer K; Jahn M; Jones S; Piequet A; Beerli C; Gram H; Goepferich A
    J Control Release; 2013 Dec; 172(3):975-82. PubMed ID: 24140353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.